NanoViricides signs confidential disclosure agreement with Viroclinics

NanoViricides reports R&D Lab, cGMP facility near construction completion NanoViricides reported that construction of the modern R&D Lab and cGMP Clinical Production facility in Shelton, Connecticut, is nearing completion on schedule.



via Shelton Newswire http://ift.tt/1fr2m0z